Key market opportunities in AI for omics studies include the demand for precision medicine, adoption of AI in drug discovery, and AI-powered multi-omics data integration. Emphasis on personalized ...

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signalling pathways to develop treatments for people living with cancer, pain, dermatologic ...

Work by an international research team led by Yu Xu and Michael Inouye at the Department of Public Health and Primary Care, University of Cambridge, has resulted in a unique resource for predicting ...

The ongoing COVID-19 pandemic has raised global concern on public health. There are major challenges ahead to develop new therapeutics and vaccines for difficult-to-target pathogens, for which we ...

Multi-omics describes the integration of multiple high-throughput screening technologies based on genomics, proteomics, transcriptomics, single-cell transcriptomics, metabolomics, and more, which all ...

Biomarkers have become essential in the diagnosis and treatment of cancer, so it’s no surprise there is a race underway to uncover more of them. Cancer biomarkers—which include inherited or acquired ...

The rapid evolution of high-throughput sequencing and mass spectrometry has positioned clinical multi-omics at the forefront of modern laboratory medicine. By analyzing multiple biological layers ...

In a recent review published in the European Journal of Immunology, a group of authors summarized current advances, challenges, and future directions in human systems immunology using multi-omics ...

Revvity, Inc. (RVTY) is a life sciences and diagnostics company that develops technologies, software, and services supporting ...